Royal Bank of Canada’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
121,828
+77,761
| +176% | +$186K | ﹤0.01% | 4547 |
|
|
2025
Q1 | $97K | Sell |
44,067
-84,741
| -66% | -$187K | ﹤0.01% | 4891 |
|
|
2024
Q4 | $702K | Sell |
128,808
-272,762
| -68% | -$1.49M | ﹤0.01% | 3401 |
|
|
2024
Q3 | $3.34M | Sell |
401,570
-24,099
| -6% | -$200K | ﹤0.01% | 2307 |
|
|
2024
Q2 | $3.05M | Buy |
425,669
+182,528
| +75% | +$1.31M | ﹤0.01% | 2321 |
|
|
2024
Q1 | $2.11M | Sell |
243,141
-134,769
| -36% | -$1.17M | ﹤0.01% | 2559 |
|
|
2023
Q4 | $2.47M | Buy |
377,910
+56,834
| +18% | +$372K | ﹤0.01% | 2471 |
|
|
2023
Q3 | $3.21M | Buy |
321,076
+98,401
| +44% | +$984K | ﹤0.01% | 2119 |
|
|
2023
Q2 | $2.77M | Buy |
222,675
+206,547
| +1,281% | +$2.57M | ﹤0.01% | 2271 |
|
|
2023
Q1 | $226K | Sell |
16,128
-5,724
| -26% | -$80.2K | ﹤0.01% | 4150 |
|
|
2022
Q4 | $313K | Buy |
21,852
+15,334
| +235% | +$220K | ﹤0.01% | 4055 |
|
|
2022
Q3 | $166K | Sell |
6,518
-42,233
| -87% | -$1.08M | ﹤0.01% | 4438 |
|
|
2022
Q2 | $1.39M | Sell |
48,751
-3,575
| -7% | -$102K | ﹤0.01% | 2841 |
|
|
2022
Q1 | $1.85M | Sell |
52,326
-47,682
| -48% | -$1.68M | ﹤0.01% | 2730 |
|
|
2021
Q4 | $4.19M | Buy |
100,008
+17,286
| +21% | +$724K | ﹤0.01% | 2156 |
|
|
2021
Q3 | $4.06M | Buy |
82,722
+62,567
| +310% | +$3.07M | ﹤0.01% | 2133 |
|
|
2021
Q2 | $840K | Buy |
20,155
+19,000
| +1,645% | +$792K | ﹤0.01% | 3410 |
|
|
2021
Q1 | $41K | Buy |
1,155
+976
| +545% | +$34.6K | ﹤0.01% | 5515 |
|
|
2020
Q4 | $5K | Buy |
+179
| New | +$5K | ﹤0.01% | 6082 |
|